Basic info
Industry
biotechnology research
Sectors
Tissue-specific Targeting
Biotechnology
Protein Conjugation
Oligonucleotide Delivery
Bispecifics
Targeted Nanoparticles
siRNA
Pharmaceutical
Drug Delivery
Licensing
Drug Discovery
Genetic Medicine
Health Care
Immunology
Protein Therapeutics
Therapeutics
Protein Engineering
Medical
Drug Development
Date founded
2018
Funding rounds raised
Total raised
$88M
from 6 investors over 6 rounds
A
Aro Biotherapeutics raised $88M on January 5, 2021
Investors: BioMotiv, Ionis Pharmaceuticals, Inc., Ridgeback Capital Management LLC, HealthCap and Northpond Ventures
A
Aro Biotherapeutics raised $13M on December 11, 2018
Investors: BioMotiv